chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Product storage error
Clinical narrative: refrigerator containing Fluzone went down to 29.1F. After that excursion, vaccine administered to patient / no AE; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2020SA032577, 2020SA038302, 2020SA038467, 2020SA038474, 2020SA038473, 2020SA038466, 2020SA038472, 2020SA038471, 2020SA038470, 2020SA038343, 2020SA038344, 2020SA038345, 2020SA038346, 2020SA038347, 2020SA038348, 2020SA038349, 2020SA038350, 2020SA038351, 2020SA038352 and 2020SA038468.  This case involves a 13 years old male patient who received 0.5 ml dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ254AC (Expiry date 30-Jun-2020) via unknown route in the right arm for Prophylactic vaccination on 15-Jan-2020.which was exposed to the temperature of 29.1F (Product storage error).  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to Product storage error temperature too low.  It was reported that refrigerator containing Fluzone went down to 29.1F and the vaccine was given to the patient inspite of being compromised.  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 10.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Product storage error
Clinical narrative: refrigerator containing Fluzone went down to 29.1F. After that excursion, vaccine administered to patient / no AE; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2020SA032577, 2020SA038302, 2020SA038467, 2020SA038474, 2020SA038473, 2020SA038466, 2020SA038472, 2020SA038471, 2020SA038343, 2020SA038344, 2020SA038345, 2020SA038346, 2020SA038347, 2020SA038348, 2020SA038349, 2020SA038350, 2020SA038351, 2020SA038352, 2020SA038468 and 2020SA038469.  This case involves a 10 years old male patient who received 0.5 ml dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ254AC (Expiry date 30-Jun-2020) via unknown route in the left deltoid for Prophylactic vaccination on 16-Jan-2020 which was exposed to refrigerator down to 29.1F.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to Product storage error temperature too low.  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Product storage error
Clinical narrative: refrigerator containing Fluzone went down to 29.1F. After that excursion, vaccine administered to patient / no AE; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2020SA032577, 2020SA038302, 2020SA038467, 2020SA038474, 2020SA038473, 2020SA038466, 2020SA038472, 2020SA038343, 2020SA038344, 2020SA038345, 2020SA038346, 2020SA038347, 2020SA038348, 2020SA038349, 2020SA038350, 2020SA038351, 2020SA038352, 2020SA038468, 2020SA038469 and 2020SA038470.  This case involves a 08 years old male patient who received 0.5 ml dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ254AC (Expiry date 30-Jun-2020) via unknown route in the left deltoid for Prophylactic vaccination on 16-Jan-2020 which was exposed to refrigerator down to 29.1F.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to Product storage error temperature too low.  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: No adverse event, Product storage error
Clinical narrative: refrigerator containing Fluzone went down to 29.1F. After that excursion, vaccine administered to patient / no AE; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from other health professional.  This case was linked to cases 2020SA032577, 2020SA038302, 2020SA038467, 2020SA038474, 2020SA038473, 2020SA038466, 2020SA038343, 2020SA038344, 2020SA038345, 2020SA038346, 2020SA038347, 2020SA038348, 2020SA038349, 2020SA038350, 2020SA038351, 2020SA038352, 2020SA038468, 2020SA038469, 2020SA038470 and 2020SA03847 (same reporter).  This case involves a 08 years old female patient who received 0.5 ml dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ254AC (Expiry date 30-Jun-2020) via unknown route in the right deltoid for Prophylactic vaccination on 17-Jan-2020 which was exposed to refrigerator down to 29.1F.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Patient did not receive any concomitant therapy.  It was an actual medication error case due to Product storage error temperature too low (Product storage error).  Patient did not have adverse event at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 10.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product storage error
Clinical narrative: refrigerator containing Fluzone went down to 29.1F. After that excursion, vaccine administered to patient / no AE; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2020SA032577, 2020SA038302, 2020SA038467, 2020SA038474, 2020SA038343, 2020SA038344, 2020SA038345, 2020SA038346, 2020SA038347, 2020SA038348, 2020SA038349, 2020SA038351, 2020SA038352, 2020SA038466, 2020SA038468, 2020SA038469, 2020SA038470, 2020SA038471 and 2020SA038472.  This case involves a 10 years old female patient who received 0.5 ml of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ254AC (Expiry date 30-Jun-2020) via unknown route in the right deltoid for Prophylactic vaccination on 17-Jan-2020 which was exposed to refrigerator down to 29.1F.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to Product storage error temperature too low.  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: No adverse event, Product storage error
Clinical narrative: refrigerator containing Fluzone went down to 29.1F. After that excursion, vaccine administered to patient / no AE; Initial information received on 07-Feb-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to cases 2020SA032577, 2020SA038302, 2020SA038467, 2020SA038343, 2020SA038344, 2020SA038345, 2020SA038346, 2020SA038347, 2020SA038348, 2020SA038349, 2020SA038350, 2020SA038351, 2020SA038352, 2020SA038466, 2020SA038468, 2020SA038469, 2020SA038470, 2020SA038471, 2020SA038472 and 2020SA038473.  This case involves a 4 years old male patient who received INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] lot UJ254AC (Expiry date 30-Jun-2020) via unknown route in the left thigh for Prophylactic vaccination on 17-Jan-2020 which was exposed to refrigerator down to 29.1F.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  It was an actual medication error case due to Product storage error temperature too low.  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: F
Vaccine: FLUC4
Symptoms: Apgar score normal, Breech presentation, Caesarean section, Foetal exposure during pregnancy
Clinical narrative: Footling breech; Vaccine foetal exposure during pregnancy; This is a spontaneous case, initially received on 11-Feb-2020, concerning a female foetus patient.  The medical history, obstetrical history and concomitant medications of patient's mother were not provided.  On 21-Oct-2019, the patient's mother was administered Flucelvax QIV [batch number: 261223; dose, route of administration, anatomical location and expiration date: not reported] (explicitly coded as Foetal exposure during pregnancy') for an unknown indication.   On an unspecified date, the patient was in footling breech position in uterus.  At gestational age of 39 weeks, the mother delivered live female neonate by caesarean method. Birth weight of neonate was 3841 g. No data was reported for head circumference and length. Appearance, pulse, grimace, activity, and respiration (APGAR) score was 8 at one minute and 9 at five minutes. No data was reported for APGAR score at ten minutes.  No major congenital malformations were identified at birth.  At the time of initial reporting, the outcome of footling breech position of foetus was not reported.  The event of footling breech position of foetus was considered serious due to the criterion of medical significance.  The reporter did not provide causality assessment to Flucelvax QIV.  This case is linked to case 202001706, the corresponding mother case.  Company comment: Reportedly, breech presentation was associated with Flucelvax QIV. The patient's mother was vaccinated during pregnancy and the event was noted on an unspecified date. Chronology is unclear. Most breech presentations seem to be chance occurrences and in up to 15% of cases, it may be due to foetal or uterine causes. Information regarding medical history was not provided. Due to lack of information, causal role of the suspect vaccine is unasseassable. Foetal exposure during pregnancy is assessed as unrelated per company's conventions.; Sender's Comments: Reportedly, breech presentation was associated with Flucelvax QIV. The patient's mother was vaccinated during pregnancy and the event was noted on an unspecified date. Chronology is unclear. Most breech presentations seem to be chance occurrences and in up to 15% of cases, it may be due to foetal or uterine causes. Information regarding medical history was not provided. Due to lack of information, causal role of the suspect vaccine is unasseassable. Foetal exposure during pregnancy is assessed as unrelated per company's conventions.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Pallor, Pulse abnormal
Clinical narrative: Patient kept for observation after immunization in exam room with mother and approximately 5 minutes after injection mother comes out stating patient feeling faint.  Patient very pale in appearance.  Staff did get her laid down and she did start responding to questions and pulse became more notable versus the weak pulse when first entering room
Age: 72.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site reaction, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Red rash (itchy and hurts) roughly 5 inches in size, running down arm, under injection site. Did not want to treat symptoms, just wanted us to be aware of reaction.
Age: 0.33
Sex: F
Vaccine: RV5
Symptoms: Decreased appetite, Irritability, Pyrexia, Weight decreased
Clinical narrative: PATIENT HAD FEVER, IRRITABILITY, POOR APPETITE AND WEIGHT LOSS
Age: 5.0
Sex: F
Vaccine: FLU4
Symptoms: Alopecia, Condition aggravated
Clinical narrative: Patient has a history of alopecia.  One week after receiving her flu shot she had a significant flare and lost about 75% of her hair
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Right upper extremity redness and swelling at injection site.  Visit to urgent care.  Diagnosed with cellulitis.  Records not available at time this report filed.
Age: 19.0
Sex: F
Vaccine: HEP
Symptoms: Injection site swelling
Clinical narrative: R deltoid swelling, noticed when awaking on 02/14/2020. Given Ibuprofen with significant improvement in symptoms.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Peripheral swelling, Skin warm, Type II hypersensitivity
Clinical narrative: Patient stated that she woke up on 2/14/20 with a large, warm, red, upper arm. The redness, swelling, and warmth extended along the entire upper arm. Advised patient to contact her primary doctor who diagnosed her with a delayed type 2 hypersensitivity reaction. She was given Cephalexin 500 mg q6h for 7d
Sex: F
Vaccine: VARZOS
Symptoms: Blindness
Clinical narrative: Vision loss; zoster-related injuries; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medication use were not provided. During 2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX), (dose, frequency, route of administration, anatomical location, lot number and expiration date were not reported) as long-term prevention of shingles and zoster-related conditions. Subsequently to the patient's vaccination, on an unknown date, the patient was treated in the emergency room for vision loss and other zoster-related injuries. As a result the patient the patient had and would continue to suffer injuries, including but not limited to: mental and physical pain and suffering; medical care for these injuries; significant medical and related expenses as result of these injuries, including but not limited to medical losses and costs include care for hospitalization,  physical care monitoring, treatment medications, and supplies; diminished capacity for enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events vision loss and herpes zoster was not recovered. Both events were considered to be related to zoster vaccine live (ZOSTAVAX). Upon internal review, the patient's vision loss was considered to be medically significant.
Sex: U
Vaccine: PNC13
Symptoms: Pain in extremity
Clinical narrative: sore painful arm for close to a month; This is a spontaneous report from contactable Physician via Pfizer Sales Representative. A patient of unspecified age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced sore painful arm for close to a month after receiving vaccine administered in the arm on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: PNC13
Symptoms: Drug ineffective, Pneumonia
Clinical narrative: patient who was administered Prevnar 13 got pneumonia a few weeks after receiving it; patient who was administered Prevnar 13 got pneumonia a few weeks after receiving it; This is a spontaneous report from a contactable healthcare professional via Pfizer Sales Representative. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported.  It was reported that patient who was administered Prevnar 13 got pneumonia a few weeks after receiving it. Outcome of the event was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the temporal relationship, the association between the event drug ineffective (pneumonia) with pneumococcal 13-valent conjugate vaccine can not be fully excluded.
Sex: M
Vaccine: MENB, UNK
Symptoms: Pyrexia, Vomiting
Clinical narrative: high fever; vomiting; This is a spontaneous report from a contactable physician received via a Pfizer sales representative. A 16-year-old male patient received 1st dose of meningococcal group b rlp2086 (TRUMENBA) with meningococcal vaccine a/c/y/w; both via unspecified routes of administration on an unspecified date at  single doses for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced high fever and vomiting on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: PNC13
Symptoms: Injection site pain
Clinical narrative: Pain at the injection site; This is a spontaneous report from a contactable Nurse via Pfizer sales representative.   A patient of unknown age and gender received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVENAR 13) at single dose for immunization on unknown date. Relevant medical history and concomitant medications were not reported. The patient experienced pain at the injection site. The outcome of the event was unknown.   No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: MENB, MNQ
Symptoms: Pyrexia, Vomiting
Clinical narrative: high fever; vomiting; This is a spontaneous report from contactable Physician via a Pfizer Sales Representative. A 16-year-old female patient received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration on an unspecified date at single dose for immunization and meningococcal vaccine conj (MENINGOCOCCAL CONJUGATE), via an unspecified route of administration on an unspecified date at unspecified dose for immunization at same visit. The patient's medical history and concomitant medications were not reported. The patient experienced high fever and vomiting on an unspecified date after use of products with outcome of unknown.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Sex: F
Vaccine: MENB, UNK
Symptoms: Pyrexia, Vomiting
Clinical narrative: high fever; vomiting; This is a spontaneous report from a contactable physician via Pfizer Sales Representative.   A 16-year-old female patient received on an unspecified date at same visit, meningococcal group b rlp2086 (TRUMENBA) at single dose and meningococcal vaccine A/C/Y/W (MCV4), both for immunization. The patient medical history and concomitant medications were not reported. On an unknown date after vaccination, the patient experienced high fever and vomiting, both non serious. The final outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Vaccination site bruising, Vaccination site discolouration
Clinical narrative: 2. Adverse effect of vaccine, initial encounter - bruising and skin discoloration on right lateral thigh at varicella vaccine site 1/31/20 - image captured in media -- no vesicles or blisters - no evidence varicella systemic infection - follow clinically - will discuss with vaccine specialist  - mom to continue to take images of area.  -- aware of reasons to RTO / seek emergent care for this
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Hello, patient has a pretty big red mark on his left leg that is swollen under the skin and feverish.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Influenza like illness, Pain
Clinical narrative: Twelve (12) hours after the shot, I experienced chills and shivering, headache, body aches, and similar flu-like symptoms which lasted only about 2 hours.  The same thing happened when I had the 1st shingles shot back in November 2019, so I knew to expect it and planned to not have anything scheduled for the next day.  I was fatigued and tired the day after the shot.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site reaction, Skin lesion, Vaccination complication
Clinical narrative: 1. Adverse effect of vaccine, initial encounter - skin reaction at Varicella injection site - no overt vesicles noted - no systemic signs of varicella infection - reviewed partially live vaccine complications - may be local skin reaction, early cellulitis or vaccine reaction - images in System - mom to update office in 48 hours  - take pictures daily - consider VAERS report   2. Skin lesion - at varicella site - no varicella infection noted - may be cellulitis from injection-  - site borders marked to track progress - mom to take images daily  - if redness spreading, would start keflex - mom aware to contact office in 2 days with update and send images in System prn
Age: 1.17
Sex: F
Vaccine: VARCEL
Symptoms: Injection site discolouration, Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Left lateral thigh with deep pink / purple indurated area with surrounding redness.  Inferior redness with warmth to touch.  Area does not appear tender to palpation.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Hyperhidrosis, Nausea, Seizure like phenomena, Syncope
Clinical narrative: During/after injection patient had syncopal/ seizure like activity. Lasted approx 35-45 seconds before patient came to. Patient was alert and oriented immediatly after episode however remained Nauseated and dizzy diaphortic. Patient was given a bottle of water, cold compress and rested. After 15-20 min patient was back to normal and back in stable condition left office with mother.
Age: 77.0
Sex: M
Vaccine: VARZOS
Symptoms: Skin lesion
Clinical narrative: Pt complained of raised, white, scaley, lesion that showed up about 1 week after his first dose of shingrix.  It was still present at the time of his second dose 60 days later.
Age: 41.0
Sex: F
Vaccine: MMR, TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Pt states day after vaccine injection noticed redness, soreness, swelling, pain and warmth at injection site.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site rash, Injection site swelling, Mobility decreased
Clinical narrative: Severe redness and swelling surrounding injection site, pt has not been able to lift her arm; she was in the ER for another reason the the ER staff palpated her reaction noting nodular bumps in the inflamed area
Age: 14.0
Sex: M
Vaccine: HEP
Symptoms: Abdominal discomfort, Discomfort, Dizziness, Loss of personal independence in daily activities, Malaise
Clinical narrative: Started feeling sick 3rd day after shot. Started as head  cold symptoms, progressed over next week into stomach upset, nausea, light headedness, overall body discomfort.  Missed school or had to be picked up early sick with stomach issues for four days. Stomach issues continued through rest of month into December. Went to urgent care Dec. 5. Continued stomach issues caused multiple school absences through Dec. 10, 2019.
Age: 14.0
Sex: M
Vaccine: HEP
Symptoms: Nasopharyngitis, Nausea
Clinical narrative: Started feeling sick 3rd day after shot. Started as head  cold symptoms, progressed over next week into stomach upset, nausea, light headedness, overall body discomfort.  Missed school or had to be picked up early sick with stomach issues for four days. Stomach issues continued through rest of month into December. Went to urgent care Dec. 5. Continued stomach issues caused multiple school absences through Dec. 10, 2019.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Burning sensation, Eye pain, Headache, Pruritus
Clinical narrative: Customer reported skin reaction including blisters, itching, burning, and some pain mainly around forehead, orbital area, and high cheekbones.    Some symptoms on and around the left elbow and left outer thigh from the knee to hip.    Symptoms around skin folds under both breasts.
Age: 15.0
Sex: M
Vaccine: HEP
Symptoms: Abdominal discomfort, Chest discomfort, Cough, Dizziness, Fatigue
Clinical narrative: Lightheadedness, body tired, stomach upset. Same symptoms for days, missed school progressed to head cold on 2/6 then sore throat 2/7,  stomach upset, lightheadedness, sore throat, reflux and cough began 2/8. Continued cough and chest discomfort ( chest cold symptoms) to date.
Age: 15.0
Sex: M
Vaccine: HEP
Symptoms: Gastrooesophageal reflux disease, Loss of personal independence in daily activities, Nasopharyngitis, Oropharyngeal pain
Clinical narrative: Lightheadedness, body tired, stomach upset. Same symptoms for days, missed school progressed to head cold on 2/6 then sore throat 2/7,  stomach upset, lightheadedness, sore throat, reflux and cough began 2/8. Continued cough and chest discomfort ( chest cold symptoms) to date.
Age: 30.0
Sex: F
Vaccine: TYP
Symptoms: Malaise, Pain, Pyrexia, Rash, Vomiting
Clinical narrative: Pt took pill # 2 at 10am 2-3-2020, by the next night at 9pm she was feverish, achy, and had emesis. Felt ill X24 hours. Did not got to the doctor, stayed home and hydrated and slept. Does not remember when she took pill # 3, which was due to be taken at 10am 2-5-2020, all she knows is that by the time she spoke with this writer on Thursday 2-6-2020 at 1pm it was not in the package. She feels she must have taken it as scheduled but she really does not remember taking it. By this time she was feeling much better, no fever and keeping food down, so took pill #4 as planned at 10am 2-7-2020. She then reported to this writer on Monday 2-10-2020 that she developed a rash all over her body.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Headache, Influenza like illness, Nausea, Pain
Clinical narrative: High fever, chills, aches, sick to stomach, head ache, flu like symptoms..
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: High fever, chills, aches, sick to stomach, head ache, flu like symptoms..
Age: 15.0
Sex: M
Vaccine: TD
Symptoms: Headache, Loss of personal independence in daily activities
Clinical narrative: Severe headache causing him to have to cease activity and go to bed, Lasted throughout day, next  day he felt residual effects, headache subsided.
Age: 41.0
Sex: F
Vaccine: FLUC4
Symptoms: Insomnia, Mobility decreased, Musculoskeletal pain, Neck pain
Clinical narrative: Patient reports burning type pain in upper shoulder and neck 24 hours after receiving vaccine dose.  Patient says she is having difficulty sleeping. and limited mobility of her arm.
Age: 0.5
Sex: F
Vaccine: DTAPHEPBIP, FLU4, HIBV, PNC13
Symptoms: Blood glucose normal, Rash, Unresponsive to stimuli
Clinical narrative: 6mo Female with mild laryngomalacia and recent URI received routine 6 months vaccines and first Flu vaccine today. A few minutes after receiving vaccines and leaving the office she was brought back by caretakers unresponsive. Patient was assessed and had normal VS, open airway, breathing spontaneously, and hemodynamically stable but minimally responsive to noxious stimuli. Finger stick glucose was 95. She developed a rash on the face and was given epinephrine due to possible anaphylactic reaction.  She was taken to the emergency room at Medical Center
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Facial paralysis, Facial paresis, Hypoaesthesia
Clinical narrative: Doctor told the patient she was having signs of bells palsy- numbness and weakness in face
Age: 0.5
Sex: M
Vaccine: DTAPHEPBIP, FLU4, PNC13, RV5
Symptoms: Altered state of consciousness, Vomiting
Clinical narrative: Vomiting and transient alteration of awareness.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Patient experienced inflammation at injection site and fever which waxed and wained and then resolved four days after injection.  Patient began with symptoms of inflammation at injection site again the week of Feb 3, 2020.  Today, Feb 14, 202 Patient's left arm at injection site is red, swollen, sore, itchy, and warm. Injection was given over one month ago, and patient reports these symptoms have come and gone over the previous month.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site warmth, Pyrexia
Clinical narrative: Patient experienced inflammation at injection site and fever which waxed and wained and then resolved four days after injection.  Patient began with symptoms of inflammation at injection site again the week of Feb 3, 2020.  Today, Feb 14, 202 Patient's left arm at injection site is red, swollen, sore, itchy, and warm. Injection was given over one month ago, and patient reports these symptoms have come and gone over the previous month.
Age: 1.17
Sex: F
Vaccine: TDAP
Symptoms: Cerumen impaction, Cough, Ear irrigation, Injection site movement impairment, Injection site pain
Clinical narrative: (On 02/14/2020, After receiving vaccine Father states patient legs became sore and patient did not want to walk. Father states child had fever of 102 F after vaccine w/ cough . Per: Provider patients fever has been improving. Provider diagnosed child with acute URI and Impacted Cerumen on Right ear; Medical Assistant attempted to perform an ear lavage on child with no success. Therefore, provider prescribed patient with Ofloxacin, Amoxicillin and  Guaifenesin and advised father to bring child in 2 weeks for follow up.
Age: 1.17
Sex: F
Vaccine: TDAP
Symptoms: Pyrexia, Upper respiratory tract infection
Clinical narrative: (On 02/14/2020, After receiving vaccine Father states patient legs became sore and patient did not want to walk. Father states child had fever of 102 F after vaccine w/ cough . Per: Provider patients fever has been improving. Provider diagnosed child with acute URI and Impacted Cerumen on Right ear; Medical Assistant attempted to perform an ear lavage on child with no success. Therefore, provider prescribed patient with Ofloxacin, Amoxicillin and  Guaifenesin and advised father to bring child in 2 weeks for follow up.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: chills, shaking, headache, exhaustion, extremely sore injection site, stomach cramps
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Tremor
Clinical narrative: chills, shaking, headache, exhaustion, extremely sore injection site, stomach cramps
Age: 1.17
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Cough, Gait disturbance, Nasal congestion, Otitis media acute, Pain in extremity
Clinical narrative: (On 02/14/2020, After receiving vaccine Father states patients legs became sore and patient is no longer wanting to walk , states child prefers crawling now. Father states child had fever of 102 F after vaccine w/ cough (Saturday and Sunday)  . Per: Provider on visit date 02/14/2020 child had no fever, nasal congestion, and rhinorrhea. Provider did diagnose pt with non-recurrent acute suppurative otitis media on Right Ear w/o spontaneous rupture of Tympanic membrane. Therefore, Provider prescribed child with Amoxicillin and Guaifenesin. Provider advised father to bring child in 2 weeks for follow up.
Age: 1.17
Sex: F
Vaccine: FLU4, TDAP
Symptoms: Pyrexia, Rhinorrhoea, Tympanic membrane perforation
Clinical narrative: (On 02/14/2020, After receiving vaccine Father states patients legs became sore and patient is no longer wanting to walk , states child prefers crawling now. Father states child had fever of 102 F after vaccine w/ cough (Saturday and Sunday)  . Per: Provider on visit date 02/14/2020 child had no fever, nasal congestion, and rhinorrhea. Provider did diagnose pt with non-recurrent acute suppurative otitis media on Right Ear w/o spontaneous rupture of Tympanic membrane. Therefore, Provider prescribed child with Amoxicillin and Guaifenesin. Provider advised father to bring child in 2 weeks for follow up.
Age: 45.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site pain
Clinical narrative: patient reported adverse pain from flu shot received 01/18/202 on 01/25/2020 patient believed there were issues with safety and sterileness of injection. patient stated had went to see md from pain in upper arm and shoulder radiating from injection site since time of shot that would not go away. md believed issue was in injection site and gave pt medication for issue, from image shown puncture if truly from shot higher than deltoid area. pt also beieved issue with injecting pharmacist opening needed then leaving
Age: 26.0
Sex: M
Vaccine: TYP
Symptoms: Urticaria
Clinical narrative: HIVES ON BOTH ARMS LEGS AND LOWER TORSO
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Mouth swelling, Swelling face
Clinical narrative: PT RECEIVED ON 2.4.20. sHE BEGIN TO HAVE FACE AND MOUTH SWELLING ON 2.13.20
Age: 52.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Headache, Pain
Clinical narrative: Severe bodyaches Headache, chills for approximately 18 hrs
Age: 16.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Culture urine negative, Differential white blood cell count normal, Full blood count normal, Influenza virus test negative, Paraesthesia
Clinical narrative: Patient reports vomiting and fever on 02/12/2020 at school. Arrived at ER at 4:30pm on 02/12/2020 with c/o vomiting, fever, carpopedal spasms, feet and facial tingling. Patient was able to move all 4 extremities and neuro was intact. Patient was given Lorazepam injection, and diphenhydramine injection while in ER along with ibuprofen. Patient condition improved and patient was discharged from ER at 7:30pm on 02/12/2020 with medication of Naproxen 500 MG twice daily for 10 days for pain. Patient seen in PCP office for follow up on 02/14/2020, patient reports minor pain in left carpal but otherwise no pain or tingling in extremeties or face. Patient is advised to continue Naproxen for 5-7 days. Patient understands and agrees to plan and will follow up with PCP in 2 weeks.
Age: 16.0
Sex: M
Vaccine: MENB, MNQ
Symptoms: Pyrexia, Tetany, Vomiting
Clinical narrative: Patient reports vomiting and fever on 02/12/2020 at school. Arrived at ER at 4:30pm on 02/12/2020 with c/o vomiting, fever, carpopedal spasms, feet and facial tingling. Patient was able to move all 4 extremities and neuro was intact. Patient was given Lorazepam injection, and diphenhydramine injection while in ER along with ibuprofen. Patient condition improved and patient was discharged from ER at 7:30pm on 02/12/2020 with medication of Naproxen 500 MG twice daily for 10 days for pain. Patient seen in PCP office for follow up on 02/14/2020, patient reports minor pain in left carpal but otherwise no pain or tingling in extremeties or face. Patient is advised to continue Naproxen for 5-7 days. Patient understands and agrees to plan and will follow up with PCP in 2 weeks.
Age: 1.6
Sex: M
Vaccine: DTAP
Symptoms: Ear infection, Erythema, Swelling
Clinical narrative: Redness and swelling 2 inch x 3 inch area redness + swelling Augmentin 600 1 tsp BID x 10 days. Doubt cellulitis but starting Augmentin for otitis
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Body temperature increased, Chest X-ray, Influenza virus test, Respiratory syncytial virus test, Seizure
Clinical narrative: Child had convulsive shaking episode at home.   Mom says temperature was 103.   Temperature in the Emergency Room 101.2
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Tremor
Clinical narrative: Child had convulsive shaking episode at home.   Mom says temperature was 103.   Temperature in the Emergency Room 101.2
Age: 11.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: Injection site red; warm to  touch and indurated.
Age: 67.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Fatigue, Intensive care, Pain, Pancreatitis acute, Pancreatitis necrotising
Clinical narrative: Patient was Shingrix and Pneumovax 23 on 1/28/2020 @ 5:05 pm.  Spouse called 2/14/2020 @ 815pm to advise us that they believe he had an adverse reaction to the vaccines.  He was sore and tired for 7 days, had 1 day of feeling like he was better and then to ER on the 8th day. He was diagnosed with acute and now necrotizing pancreatitis and is in the ICU. She did not elaborate on the symptoms or treatments.
Age: 67.0
Sex: M
Vaccine: PPV, VARZOS
Symptoms: Vaccination complication
Clinical narrative: Patient was Shingrix and Pneumovax 23 on 1/28/2020 @ 5:05 pm.  Spouse called 2/14/2020 @ 815pm to advise us that they believe he had an adverse reaction to the vaccines.  He was sore and tired for 7 days, had 1 day of feeling like he was better and then to ER on the 8th day. He was diagnosed with acute and now necrotizing pancreatitis and is in the ICU. She did not elaborate on the symptoms or treatments.
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Patient spouse called & said on day 2 (possible evening of day 1) patient experience n/v and dizziness.  Discussed Shingrix side effects and other possible causes including influenza, heart issues, etc.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chills, Fatigue, Headache, Influenza like illness
Clinical narrative: Pain and redness at injection site,  severe shivering, went to bed with heavy nightwear and four blankets that lasted for approximately 6 hours, afterward and continuation the following day tiredness, fever, muscle pain, upset stomach, headache....symptoms would be similar to flu
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pain, Myalgia, Pyrexia
Clinical narrative: Pain and redness at injection site,  severe shivering, went to bed with heavy nightwear and four blankets that lasted for approximately 6 hours, afterward and continuation the following day tiredness, fever, muscle pain, upset stomach, headache....symptoms would be similar to flu
Age: 12.0
Sex: F
Vaccine: TD
Symptoms: Hypoaesthesia, Injected limb mobility decreased, Injection site pain, Myalgia, Sensory loss
Clinical narrative: Approximately two hours after receiving the Td vaccine, my daughter complained of extreme numbness and inability to move her entire left arm.  Additionally, she felt pain into her lower Trapezius muscle, and also could not feel the sensation of strokes and pressure touches to her skin along her arm, or left hand.  This occurred for over four more hours.  She was monitored continually to see if any improvement  in moving her arm, but there was none. She was given Tylenol to mediate the pain in her upper shoulder, and used an ice pack. She finally fell asleep around 11 p.m., or so.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pruritus, Pyrexia, Rash
Clinical narrative: itch,rash over whole body, fever  and zoster in neck
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cardiac failure congestive
Clinical narrative: Pt presents to ER with symptoms of CHF. Patient had no history of any heart problems.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cardiac failure congestive, Catheterisation cardiac, Chest X-ray, Computerised tomogram, Echocardiogram
Clinical narrative: Pt presents to ER with symptoms of CHF. Patient had no history of any heart problems.
Age: 73.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Laboratory test, Pulmonary oedema, Swelling, Ventilation/perfusion scan
Clinical narrative: Pt presents to ER with symptoms of CHF. Patient had no history of any heart problems.
Age: 75.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash macular
Clinical narrative: The day after the shot i woke up with red blotches on my arms and legs.  2 on my face, none on my stomach, or back.  they did itch.  I had an appointment with the dermotologist the next day and she said that it was just a reaction and to apply benedral which I did and after a couple of days it went away.
Age: 59.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Joint swelling, Pain
Clinical narrative: body aches and joint pain behind knees in the first few days and lasted for several days. The recent and most alarming event is the swelling right knee that is noticeable. Will see doctor on Tuesday if symptoms persist
Age: 59.0
Sex: M
Vaccine: VARZOS, VARZOS
Symptoms: Arthralgia, Blood test, Joint swelling, X-ray
Clinical narrative: body aches and joint pain behind knees in the first few days and lasted for several days. The recent and most alarming event is the swelling right knee that is noticeable. Will see doctor on Tuesday if symptoms persist
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Hypersensitivity, Injection site erythema, Injection site reaction, Injection site swelling
Clinical narrative: Hypersensitivity reaction at the site (5-6cm asymmetric annual erythema with visible small bump from injection site)
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Bone contusion, Immediate post-injection reaction, Inflammation, Joint effusion, Loss of personal independence in daily activities
Clinical narrative: Patient states she had pain immediately following the vaccination on 10/02/2019. She went and saw her primary care physician on 10/29/2019 because she was still having pain. She was then to follow up with an orthopedic surgeon to further assess the issue. She had an appointment with Dr. 11/27/19 where he prescribed a steroid medication. Prior to the appointment he ordered a MRI which was resulted on 12/2/19 and showed a bone bruise, fluid in the shoulder area and a partially torn rotator cuff per the patient. She was later prescribed an anti-inflammatory on 12/13/19 for persisting pain and inflammation. During this time she has also seen her PT that noted that she was unable to perform shoulder exercises due to her condition. She is following up with Dr in the coming weeks.
Age: 39.0
Sex: F
Vaccine: FLU4
Symptoms: Pain, Rotator cuff syndrome
Clinical narrative: Patient states she had pain immediately following the vaccination on 10/02/2019. She went and saw her primary care physician on 10/29/2019 because she was still having pain. She was then to follow up with an orthopedic surgeon to further assess the issue. She had an appointment with Dr. 11/27/19 where he prescribed a steroid medication. Prior to the appointment he ordered a MRI which was resulted on 12/2/19 and showed a bone bruise, fluid in the shoulder area and a partially torn rotator cuff per the patient. She was later prescribed an anti-inflammatory on 12/13/19 for persisting pain and inflammation. During this time she has also seen her PT that noted that she was unable to perform shoulder exercises due to her condition. She is following up with Dr in the coming weeks.
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Injection site induration, Injection site pain, Limb mass, Pain in extremity
Clinical narrative: Patient reports that yesterday night on 02/14/2020 her right arm felt sore and she felt a lump there, the symptoms once began did not get better or worse. She reported the symptoms to her supervisor when she arrived at work on 02/15/2020. Patient works at a company that has their nurses give their own employees the Hep B vaccine, and her vaccine was administered here at our center on 02/06/2020. A Nurse inspected right arm and there was no drainage, no redness, no warmth, but there was  palpated area of induration approx. 0.5cm x 0.5cm and mild pain at site. Cold pack provided with no relief. Health management notified, Patient states she has an established appointment with her PCP on 01/17/2020 and will follow up there.
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal pain upper, Arthralgia, Headache, Hypersomnia, Joint range of motion decreased
Clinical narrative: I felt lethargic for 2 days and slept and could not get out of bed. I had nausea, stomach cramps, severe headache, joint ache, and swelling and pain in left finger joint and right knee. Still can not move knee after 4 days
Age: 71.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint swelling, Lethargy, Nausea, Pain in extremity, Peripheral swelling
Clinical narrative: I felt lethargic for 2 days and slept and could not get out of bed. I had nausea, stomach cramps, severe headache, joint ache, and swelling and pain in left finger joint and right knee. Still can not move knee after 4 days
Age: 26.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site nodule, Injection site pruritus
Clinical narrative: Patient called to report small knot and itching at injection site. No other symptoms.
Age: 0.25
Sex: F
Vaccine: DTAP
Symptoms: Pruritus, Rash
Clinical narrative: Woke up with a rash all over her body and face, itching
Age: 50.0
Sex: F
Vaccine: FLUR4
Symptoms: Pain, Product administered at inappropriate site, Sleep disorder, X-ray limb
Clinical narrative: The flu shot was administered too high on the arm (up in the shoulder area)  and led to a lot of pain and sleeping problems for approximately two months.  This incorrectly administered shot forced patient to visit the Doctor three times and a Physical Therapist once.  Although patient is still not 100%, the shoulder is not bothering her much anymore, and we do not believe there is any permanent damage from the improperly administered flu shot.
Age: 55.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Peripheral swelling, Pyrexia
Clinical narrative: Patient's arm was swollen, red, and also had a fever.  She started taking tylenol for the fever.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Gait disturbance, Headache, Injection site pain, Injection site swelling
Clinical narrative: Swollen sore arm where injected, headache and fever.  Swollen painful knee. One week after shot, still have trouble walking.